Task: Answer the multiple choice question.
Question: Which drug has a -46.448% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1ccc(S(=O)(=O)C(NC(=O)c2ccccc2)=C(Cl)Cl)cc1
(b) C#CCN(C(=O)c1ccc(OC)c(OC2CCN(C(C)C)CC2)c1)C1CCCCC1
Answer: b. C#CCN(C(=O)c1ccc(OC)c(OC2CCN(C(C)C)CC2)c1)C1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCN(C(=O)c1ccc(OC)c(OC2CCN(C(C)C)CC2)c1)C1CCCCC1
C#CCN(C(=O)c1ccc(OC)c(OC2CCN(C(C)C)CC2)c1)C1CCCCC1
N-cyclohexyl-4-methoxy-3-(1-propan-2-ylpiperidin-4-yl)oxy-N-prop-2-ynylbenzamide